论文部分内容阅读
预防食道静脉曲张出血曾推荐用手术治疗。近年来,由于手术后死亡率高,已不太主张手术治疗。本文对11例65岁以上食道静脉出血的患者在内窥镜下注射硬化剂疗法作一报道。上述病例包括隐原性肝硬化6例,酒精性肝病3例和非甲非乙型肝炎2例。各例均因严重肝病而未手术,并有以下问题:老年,减压术未成功者,出血情况经注射硬化剂、应用三腔管(Sengstaken Blakemore tube)、注射垂体后叶素最初得到控制,或者出血已有自动停止者。方法是经曲张的静脉内注射5％鱼肝油酸钠,或0.75％ Tetra—decyl和50％葡萄糖。首次作硬化疗法的平均年龄为74岁(65～88岁)。首次硬化疗
Prevent esophageal variceal bleeding was recommended surgery. In recent years, due to the high postoperative mortality rate, surgery has not been advocated. In this paper, 11 cases of esophageal bleeding over the age of 65 patients with endoscopic injection of sclerotherapy for a report. The above cases include 6 cases of cryptogenic cirrhosis, 3 cases of alcoholic liver disease and 2 cases of non-A, non-B hepatitis. Each case was due to severe liver disease without surgery, and the following problems: elderly, decompression fails, the bleeding through the injection of sclerosing agent, the application of three-chamber tube (Sengstaken Blakemore tube), injection of pituitrin initially controlled, Or hemorrhage has been automatically stopped. The method is varicose vein injection of 5% sodium morrhuate, or 0.75% Tetra-decyl and 50% glucose. The average age for initial sclerotherapy is 74 years (65 to 88 years). First sclerotherapy